This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
MM Denniston ,
Chronic hepatitis C virus infection in the United States, national health and nutrition examination survey 2003 to 2010. Annals of Internal Medicine
2014; 160: 293–300.
IM Jacobson ,
Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clinical Gastroenterology and Hepatology
2010; 8: 924–933.
RM Klevens ,
Evolving epidemiology of hepatitis C virus in the United States. Clinical Infectious Diseases
2012; 55: S3–S9.
KN Ly ,
Rising mortality associated with hepatitis C virus in the United States, 2003–2013. Clinical Infectious Diseases
2016; 62: 1287–1288.
H Razavi ,
Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology
2013; 57: 2164–2170.
ML Shiffman . Hepatitis C virus therapy in the direct acting antiviral era. Current Opinion in Gastroenterology
2014; 30: 217–222.
MD Stein , J Maksad , J Clarke . Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence
2001; 61: 211–215.
CE McGowan , MW Fried . Barriers to hepatitis C treatment. Liver International
2012; 32: 151–156.
JW Ward , DB Rein , BD Smith . Data to guide the ‘test and treat era’ of hepatitis C. Gastroenterology
2012; 143: 887–889.
M Kabiri ,
The changing burden of hepatitis C virus infection in the United States: Model-based predictions. Annals of Internal Medicine
2014; 161: 170–180.
S Barua ,
Restrictions for medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Annals of Internal Medicine
2015; 163: 215–223.
JT Nguyen ,
A budget impact analysis of newly available hepatitis C therapeutics and the financial burden on a state correctional system. Journal of Urban Health
2015; 92: 635–649.
H Razavi ,
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. Journal of Viral Hepatitis
2014; 21: 34–59.
HH Thein ,
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression. Hepatology
2008; 48: 418–431.
K Sennfält ,
Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in sweden. Scandinavian Journal of Gastroenterology
2001; 36: 870–876.
AJ Freeman ,
Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology
2001; 34: 809–816.
B Fu , W Wang , X Shi . Impact of delayed diagnosis time in estimating progression rates to hepatitis C virus-related cirrhosis and death. Statistical Methods in Medical Research
2015; 24: 693–710.
JM Micallef , JM Kaldor , GJ Dore . Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. Journal of Viral Hepatitis
2006; 13: 34–41.
S Onofrey ,
Underascertainment of acute hepatitis C virus infections in the U.S. Surveillance system: a case series and chart review. Annals of Internal Medicine
2015; 163: 254–261.
BR Edlin ,
Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology
2015; 62: 1353–1363.
SD Holmberg ,
Hepatitis C in the United States. New England Journal of Medicine
2013; 368: 1859–1861.
GL Davis ,
Aging of hepatitis C virus (HCV)-infected persons in the United States: A multiple cohort model of HCV prevalence and disease progression. Gastroenterology
2010; 138: 513–521.
P Bruggmann ,
Historical epidemiology of hepatitis C virus (HCV) in selected countries. Journal of Viral Hepatitis
2014; 21: 5–33.
ML Volk ,
Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology
2009; 50: 1750–1755.
D Kershenobich ,
Applying a system approach to forecast the total hepatitis C virus-infected population size: Model validation using US data. Liver International
2011; 31: 4–17.
S Boccato ,
Fibrosis progression in initially mild chronic hepatitis C. Journal of Viral Hepatitis
2006; 13: 297–302.
R Mahajan ,
Mortality among persons in care with hepatitis C virus infection: The chronic hepatitis cohort study (CHeCS), 2006–2010. Clinical Infectious Diseases
2014; 58: 1055–1061.
R Sacks-Davis ,
Hepatitis C virus reinfection and spontaneous clearance of reinfection – the inc3 study. Journal of Infectious Diseases
2015; 212: 1407–1419.
B Müllhaupt ,
Modeling the health and economic burden of hepatitis C virus in switzerland. PLoS ONE
2015; 10: e0125214.
HS Chahal ,
Cost-effectiveness of early treatment of hepatitis C virus genotype 1 by stage of liver fibrosis in a US treatment-naive population. JAMA Internal Medicine
2016; 176: 65–73.